CN102772497A - 热淋清颗粒药材醇提有效部位及其制备方法 - Google Patents
热淋清颗粒药材醇提有效部位及其制备方法 Download PDFInfo
- Publication number
- CN102772497A CN102772497A CN2012102998719A CN201210299871A CN102772497A CN 102772497 A CN102772497 A CN 102772497A CN 2012102998719 A CN2012102998719 A CN 2012102998719A CN 201210299871 A CN201210299871 A CN 201210299871A CN 102772497 A CN102772497 A CN 102772497A
- Authority
- CN
- China
- Prior art keywords
- methanol
- herba polygoni
- polygoni capitati
- eluted fractions
- retention time
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims abstract description 21
- 238000000605 extraction Methods 0.000 title abstract description 6
- 239000008187 granular material Substances 0.000 title abstract description 6
- 239000000463 material Substances 0.000 title abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 90
- 239000000284 extract Substances 0.000 claims abstract description 88
- 239000002904 solvent Substances 0.000 claims abstract description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 35
- 239000011347 resin Substances 0.000 claims abstract description 34
- 229920005989 resin Polymers 0.000 claims abstract description 34
- 239000000047 product Substances 0.000 claims abstract description 29
- 239000000203 mixture Substances 0.000 claims abstract description 27
- 238000010828 elution Methods 0.000 claims abstract description 18
- 238000010992 reflux Methods 0.000 claims abstract description 13
- 239000003480 eluent Substances 0.000 claims abstract description 12
- 230000014759 maintenance of location Effects 0.000 claims description 72
- 229930182486 flavonoid glycoside Natural products 0.000 claims description 54
- 150000007955 flavonoid glycosides Chemical class 0.000 claims description 54
- 238000000034 method Methods 0.000 claims description 44
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 claims description 30
- 239000003814 drug Substances 0.000 claims description 27
- FFNTWLBZRJZJEJ-PYGBXMOSSA-N Granatin B Chemical compound O([C@H]1[C@@H]2OC(=O)C=3C4C5=C(C(O[C@H]6[C@@H]2OC(=O)C2=CC(O)=C(O)C(O)=C2C2=C(O)C(O)=C(O)C=C2C(=O)OC[C@H]6O1)=O)C=C(C(=C5OC4(O)C(O)(O)C(=O)C=3)O)O)C(=O)C1=CC(O)=C(O)C(O)=C1 FFNTWLBZRJZJEJ-PYGBXMOSSA-N 0.000 claims description 24
- 229920002273 Granatin B Polymers 0.000 claims description 24
- QCCCZTBAYDERBM-XSZDUELUSA-N carpinusin Natural products O[C@@H]1OC[C@@H]2O[C@@H](OC(=O)c3cc(O)c(O)c(O)c3c4c(O)c(O)c(O)cc14)[C@H]5OC(=O)c6cc(O)c(O)c7O[C@@]8(O)C(=O)C=C([C@@H](c67)C8(O)O)C(=O)O[C@H]2[C@H]5OC(=O)c9cc(O)c(O)c(O)c9 QCCCZTBAYDERBM-XSZDUELUSA-N 0.000 claims description 24
- QCCCZTBAYDERBM-NLPUGBIRSA-N carpinusin Chemical compound O([C@@H]1[C@@H]2OC(=O)C3=CC(=O)C4(O)OC=5C(O)=C(O)C=C(C=5C3C4(O)O)C(=O)O[C@@H]1[C@H]1O[C@@H]2COC(C2=CC(O)=C(O)C(O)=C2C2=C(O)C(O)=C(O)C=C2C(=O)O1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 QCCCZTBAYDERBM-NLPUGBIRSA-N 0.000 claims description 24
- FFNTWLBZRJZJEJ-UHFFFAOYSA-N granatin B Natural products C=1C(=O)C(O)(O)C2(O)OC3=C(O)C(O)=CC(C(OC4C5OC(=O)C6=CC(O)=C(O)C(O)=C6C6=C(O)C(O)=C(O)C=C6C(=O)OCC4O4)=O)=C3C2C=1C(=O)OC5C4OC(=O)C1=CC(O)=C(O)C(O)=C1 FFNTWLBZRJZJEJ-UHFFFAOYSA-N 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 21
- 229940079593 drug Drugs 0.000 claims description 20
- DZAITDYEHYKPKZ-UHFFFAOYSA-N 2-Galloylglucose Natural products OC1C(O)C(CO)OC(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 DZAITDYEHYKPKZ-UHFFFAOYSA-N 0.000 claims description 15
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 claims description 15
- 229930182470 glycoside Natural products 0.000 claims description 15
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims description 15
- 235000008777 kaempferol Nutrition 0.000 claims description 15
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 claims description 15
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 claims description 15
- 238000012360 testing method Methods 0.000 claims description 15
- 238000010168 coupling process Methods 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- 238000001269 time-of-flight mass spectrometry Methods 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 11
- QOKISIDHCPDXMC-UHFFFAOYSA-N (+)-5'-methoxyisolacriciresinol-9'-beta-D-xylopyranoside Natural products C=1C(OC)=C(O)C(OC)=CC=1C1C=2C=C(O)C(OC)=CC=2CC(CO)C1COC1OCC(O)C(O)C1O QOKISIDHCPDXMC-UHFFFAOYSA-N 0.000 claims description 10
- GWDZRGQRNHELQM-NHJKQUFYSA-N (2r,3r,4s,5r)-2-[[(1r,2s,3s)-7-hydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-6,8-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methoxy]oxane-3,4,5-triol Chemical compound C([C@@H]1[C@@H](CO)CC=2C=C(C(=C(OC)C=2[C@H]1C=1C=C(OC)C(O)=C(OC)C=1)O)OC)O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O GWDZRGQRNHELQM-NHJKQUFYSA-N 0.000 claims description 10
- GWDZRGQRNHELQM-VXZQQKRVSA-N Lyoniside Natural products O(C[C@@H]1[C@@H](c2cc(OC)c(O)c(OC)c2)c2c(OC)c(O)c(OC)cc2C[C@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)CO1 GWDZRGQRNHELQM-VXZQQKRVSA-N 0.000 claims description 10
- GWDZRGQRNHELQM-QWMLTHFVSA-N Nudiposide Natural products O(C[C@H]1[C@H](c2cc(OC)c(O)c(OC)c2)c2c(OC)c(O)c(OC)cc2C[C@@H]1CO)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)CO1 GWDZRGQRNHELQM-QWMLTHFVSA-N 0.000 claims description 10
- 208000004880 Polyuria Diseases 0.000 claims description 10
- 230000035619 diuresis Effects 0.000 claims description 10
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 10
- 239000000725 suspension Substances 0.000 claims description 10
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 claims description 9
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 claims description 9
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 9
- 229930003944 flavone Natural products 0.000 claims description 9
- 150000002212 flavone derivatives Chemical class 0.000 claims description 9
- 235000011949 flavones Nutrition 0.000 claims description 9
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 claims description 9
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 9
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 7
- AWFYPPSBLUWMFQ-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=C2 AWFYPPSBLUWMFQ-UHFFFAOYSA-N 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 5
- 206010037596 Pyelonephritis Diseases 0.000 claims description 5
- XBJFCYDKBDVADW-UHFFFAOYSA-N acetonitrile;formic acid Chemical compound CC#N.OC=O XBJFCYDKBDVADW-UHFFFAOYSA-N 0.000 claims description 5
- 238000003556 assay Methods 0.000 claims description 5
- 238000000889 atomisation Methods 0.000 claims description 5
- 238000010790 dilution Methods 0.000 claims description 5
- 239000012895 dilution Substances 0.000 claims description 5
- 235000019253 formic acid Nutrition 0.000 claims description 5
- 238000001819 mass spectrum Methods 0.000 claims description 5
- 230000001105 regulatory effect Effects 0.000 claims description 5
- 238000010183 spectrum analysis Methods 0.000 claims description 5
- 230000036592 analgesia Effects 0.000 claims description 4
- 230000003115 biocidal effect Effects 0.000 claims description 4
- 230000001939 inductive effect Effects 0.000 claims description 4
- 208000015181 infectious disease Diseases 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 208000011580 syndromic disease Diseases 0.000 claims description 4
- 230000002485 urinary effect Effects 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 230000001737 promoting effect Effects 0.000 claims description 3
- 201000007094 prostatitis Diseases 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 2
- 241000764065 Persicaria capitata Species 0.000 abstract description 4
- 238000001914 filtration Methods 0.000 abstract description 4
- 238000001035 drying Methods 0.000 abstract description 3
- 239000000706 filtrate Substances 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 238000011068 loading method Methods 0.000 abstract 1
- 238000004064 recycling Methods 0.000 abstract 1
- 238000009210 therapy by ultrasound Methods 0.000 abstract 1
- 239000000499 gel Substances 0.000 description 14
- 239000000523 sample Substances 0.000 description 14
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 230000001629 suppression Effects 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 230000001047 pyretic effect Effects 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 239000004793 Polystyrene Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000945 filler Substances 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 238000001802 infusion Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 229920002223 polystyrene Polymers 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000012567 medical material Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 240000006409 Acacia auriculiformis Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000588653 Neisseria Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001741 anti-phlogistic effect Effects 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 206010059517 Bacterial pyelonephritis Diseases 0.000 description 1
- 241000094396 Bolitoglossa carri Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical group ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 1
- 206010014025 Ear swelling Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
- 241000205407 Polygonum Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000002814 agar dilution Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000002389 essential drug Substances 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229960003883 furosemide Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Images
Landscapes
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
时间(min) | A(%) | B(%) |
0 | 95 | 5 |
0.5 | 95 | 5 |
20 | 81.5 | 18.5 |
28 | 0 | 100 |
30 | 0 | 100 |
30.1 | 95 | 5 |
32 | 95 | 5 |
时间(min) | A(%) | B(%) |
0 | 95 | 5 |
0.5 | 95 | 5 |
20 | 81.5 | 18.5 |
28 | 0 | 100 |
30 | 0 | 100 |
30.1 | 95 | 5 |
32 | 95 | 5 |
组别 | 剂量(g/kg) | n | 肿胀抑制率(%) |
对照组 | - | 10 | |
头花蓼水提物 | 5 | 10 | 29.2 |
有效部位E | 2.5 | 10 | 43.3 |
有效部位F | 2.5 | 10 | 37.2 |
有效部位G | 2.5 | 10 | 36.4 |
有效部位Y | 2.5 | 10 | 39.58 |
试药 | 抑制率分级 |
部位E | AAAA* |
部位F | AAAA** |
部位G | AAAAA** |
部位Y | AAAAA** |
头花蓼水提物 | AAAA** |
时间(min) | A(%) | B(%) |
0 | 95 | 5 |
0.5 | 95 | 5 |
20 | 81.5 | 18.5 |
28 | 0 | 100 |
30 | 0 | 100 |
30.1 | 95 | 5 |
32 | 95 | 5 |
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210299871.9A CN102772497B (zh) | 2012-08-22 | 2012-08-22 | 热淋清颗粒药材醇提有效部位及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210299871.9A CN102772497B (zh) | 2012-08-22 | 2012-08-22 | 热淋清颗粒药材醇提有效部位及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102772497A true CN102772497A (zh) | 2012-11-14 |
CN102772497B CN102772497B (zh) | 2014-03-26 |
Family
ID=47117754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210299871.9A Active CN102772497B (zh) | 2012-08-22 | 2012-08-22 | 热淋清颗粒药材醇提有效部位及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102772497B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015061934A1 (zh) * | 2013-10-30 | 2015-05-07 | 浙江三正生物科技有限公司 | 一种头花蓼提取物及其应用和含有该头花蓼提取物的制剂 |
CN108226306A (zh) * | 2017-12-27 | 2018-06-29 | 贵州威门药业股份有限公司 | 头花蓼不同浓度乙醇提取物的指纹图谱的测定方法 |
CN110464755A (zh) * | 2019-09-17 | 2019-11-19 | 河南百年康鑫药业有限公司 | 一种治疗急性肾盂肾炎的中药组合物片剂 |
WO2024077489A1 (zh) * | 2022-10-11 | 2024-04-18 | 贵州威门药业股份有限公司 | 改进热淋清颗粒生物学活性的方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101940625A (zh) * | 2010-09-07 | 2011-01-12 | 中国中医科学院中药研究所 | 一种提取物的制备方法及其用途 |
-
2012
- 2012-08-22 CN CN201210299871.9A patent/CN102772497B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101940625A (zh) * | 2010-09-07 | 2011-01-12 | 中国中医科学院中药研究所 | 一种提取物的制备方法及其用途 |
Non-Patent Citations (2)
Title |
---|
李咏梅等: "头花蓼的化学成分及药理研究进展", 《贵州大学学报(自然科学版)》, no. 02, 30 March 2007 (2007-03-30), pages 205 - 207 * |
赵焕新等: "头花蓼化学成分及其分析方法研究进展", 《食品与药品》, vol. 12, no. 11, 31 December 2010 (2010-12-31), pages 13 - 15 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015061934A1 (zh) * | 2013-10-30 | 2015-05-07 | 浙江三正生物科技有限公司 | 一种头花蓼提取物及其应用和含有该头花蓼提取物的制剂 |
CN108226306A (zh) * | 2017-12-27 | 2018-06-29 | 贵州威门药业股份有限公司 | 头花蓼不同浓度乙醇提取物的指纹图谱的测定方法 |
CN110464755A (zh) * | 2019-09-17 | 2019-11-19 | 河南百年康鑫药业有限公司 | 一种治疗急性肾盂肾炎的中药组合物片剂 |
CN110464755B (zh) * | 2019-09-17 | 2021-07-20 | 河南百年康鑫药业有限公司 | 一种治疗急性肾盂肾炎的中药组合物片剂 |
WO2024077489A1 (zh) * | 2022-10-11 | 2024-04-18 | 贵州威门药业股份有限公司 | 改进热淋清颗粒生物学活性的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102772497B (zh) | 2014-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102772499B (zh) | 热淋清颗粒原料的醇提有效部位及其制备方法和用途 | |
CN102772500B (zh) | 具有抗炎作用的热淋清颗粒原料头花蓼提取物 | |
CN103816296B (zh) | 紫珠总苷提取物及其制备方法和用途 | |
CN101940625B (zh) | 一种提取物的制备方法 | |
CN102526219B (zh) | 热淋清颗粒提取物及其制备方法和用途 | |
CN101904948B (zh) | 一种新众生丸的中药制剂及其制备方法 | |
Zhang et al. | Comparative pharmacokinetics of baicalin, wogonoside, baicalein and wogonin in plasma after oral administration of pure baicalin, radix scutellariae and scutellariae-paeoniae couple extracts in normal and ulcerative colitis rats | |
CN101152261A (zh) | 连翘(果实或叶)中苯乙醇苷类和木质素苷类组分的应用 | |
CN102805767B (zh) | 具有抗***作用的热淋清颗粒原料头花蓼提取物 | |
CN102772497B (zh) | 热淋清颗粒药材醇提有效部位及其制备方法 | |
CN101664446A (zh) | 热淋清浸膏及其制备方法和用途 | |
CN102526218B (zh) | 制备头花蓼提取物的方法和头花蓼提取物 | |
CN102134192A (zh) | 金银花提取绿原酸的制备方法和金银花提取物的应用 | |
CN1965894B (zh) | 一种具免疫活性的夏枯草多糖组合物及其制备方法和应用 | |
CN102342945B (zh) | 救必应皂苷化合物用于制备抗炎镇痛药物 | |
CN101250175A (zh) | 杨梅素的制备方法、药物制剂及医药新用途 | |
CN1947747B (zh) | 由木犀草素和连翘制成的药物组合物及其制备方法和用途 | |
CN101549010B (zh) | 一种补骨脂总苷提取物的制备方法及应用 | |
CN104000881A (zh) | 一种具有抗菌活性的葎草有效部位及其应用 | |
CN101024663A (zh) | 一种新化合物、含有该化合物的提取物及制备方法和应用 | |
CN100528205C (zh) | 一种开口箭提取物、含有开口箭提取物的药物组合物及其制备方法和用途 | |
CN102228666B (zh) | 来自松花粉与姜黄的组合物及其制备方法和在制备治疗炎症性肠病的药物中的应用 | |
CN1969895A (zh) | 穿心莲肠溶制剂及制备方法 | |
CN107260810A (zh) | 高纯度丁香叶总环烯醚萜苷提取物及其制剂的制备方法及用途 | |
CN101721437B (zh) | 用于治疗慢性咽炎的药物组合物的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Alcohol extraction effective part of medicinal material of Relinqing granules and preparation method thereof Effective date of registration: 20140807 Granted publication date: 20140326 Pledgee: Agricultural Bank of China Limited by Share Ltd. Guiyang Xinhua Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: 2014990000643 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20180926 Granted publication date: 20140326 Pledgee: Agricultural Bank of China Limited by Share Ltd. Guiyang Xinhua Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: 2014990000643 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Alcohol extraction effective part of medicinal material of Relinqing granules and preparation method thereof Effective date of registration: 20180926 Granted publication date: 20140326 Pledgee: Agricultural Bank of China Limited by Share Ltd. Guiyang branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: 2018990000887 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PM01 | Change of the registration of the contract for pledge of patent right |
Change date: 20191128 Registration number: 2018990000887 Pledgee after: Agricultural Bank of China Limited by Share Ltd. Guiyang Xinhua Branch Pledgee before: Agricultural Bank of China Limited by Share Ltd. Guiyang branch |
|
PM01 | Change of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230223 Granted publication date: 20140326 Pledgee: Agricultural Bank of China Limited by Share Ltd. Guiyang Xinhua Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: 2018990000887 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Effective parts extracted by alcohol from Relinqing granules and its preparation method Effective date of registration: 20230223 Granted publication date: 20140326 Pledgee: Agricultural Bank of China Limited by Share Ltd. Guiyang Xinhua Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: Y2023990000128 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |